US58933Y1055 - Common Stock
MERCK & CO. INC.
NYSE:MRK (3/27/2024, 8:04:00 PM)
Premarket: 132.49 +0.74 (+0.56%)131.75
+6.23 (+4.96%)
Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. The company is headquartered in Kenilworth, New Jersey and currently employs 69,000 full-time employees. The firm offers health solutions through its prescription medicines, including biological therapies, vaccines and animal health products. The Company’s Pharmaceutical segment includes human health pharmaceutical and vaccine products. Its human health pharmaceutical products consist of therapeutic and preventive agents, generally sold by prescription for the treatment of human disorders. The company sells human health pharmaceutical products to drug wholesalers and retailers, hospitals, government agencies and managed healthcare providers. The Company’s Animal Health segment develops, manufactures and markets a range of veterinary pharmaceutical and vaccine products as well as health management solutions for the prevention, treatment and control of disease in all livestock and companion animal species. The Company’s product MK-7240 is used for the treatment of immune-mediated diseases including ulcerative colitis, and Crohn’s disease.
MERCK & CO. INC.
2000 Galloping Hill Road
Kenilworth NEW JERSEY 07033
P: 19087404000
CEO: Kenneth C. Frazier
Employees: 69000
Website: https://www.merck.com/
Stay informed about the performance of the S&P500 index one hour before the close of the markets on Wednesday. Uncover the top gainers and losers in today's session for valuable insights.
Cantor Fitzgerald notes Merck's robust stock performance, up 15% YTD vs S&P 500's 10%.Potential peak sales projections ranging from $1 billion to $8 billion. Merck targets 40,000 potential patients.
Stay updated with the movements of the S&P500 index in the middle of the day on Wednesday. Discover which stocks are leading as top gainers and losers in today's session.
Before the opening bell on Wednesday, let's take a glimpse of the US markets and explore the S&P500 top gainers and losers in today's pre-market session.
Here you can normally see the latest stock twits on MRK, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: